Picture of ValiRx logo

VAL ValiRx News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

REG - ValiRx PLC - Change of Adviser <Origin Href="QuoteRef">VALX.L</Origin>

RNS Number : 9995O
ValiRx PLC
03 June 2015

3 June 2015

ValiRx Plc

('ValiRx' or the 'Company')

Change of Adviser

London, UK, 3 June 2015 - ValiRx Plc (AIM: VAL), a life science company with a focus on cancer therapeutics and diagnostics for personalised medicine, announces that Northland Capital Partners Limited has been appointed sole broker to the Company with immediate effect.

ValiRx Plc

Tel: +44 (0)20 3008 4416

Dr Satu Vainikka

www.ValiRx.com

Cairn Financial Advisers LLP (Nominated Adviser)

Tel: +44 (0)20 7148 7900

Liam Murray / Avi Robinson

Northland Capital Partners Limited (Broker)

Tel: +44 (0)20 7382 1100

Patrick Claridge / John Howes / Abigail Wayne

Peckwater PR

Tel: +44 (0)7879 458 364

Tarquin Edwards

tarquin.edwards@peckwaterpr.co.uk


This information is provided by RNS
The company news service from the London Stock Exchange
END
APPFMGGVKZMGKZM

Recent news on ValiRx

See all news